Please login to the form below
Chiesi
This page shows the latest Chiesi news and features for those working in and with pharma, biotech and healthcare.
AZ prepares to file COPD triple, taking on rival GSK
First to market in Europe was Chiesi with its Trimbow (formoterol fumarate, glycopyrronium and beclomethasone) product, although this has to be administered twice-daily while Trelegy and PT010 are dosed just
Latest news
-
Chiesi targets patient adherence via mobile app
Chiesi targets patient adherence via mobile app. Initiative will see asthma and COPD patients receive device training support. ... Patients using Chiesi’s app will be able to review their inhaler technique and can share this during their consultations
-
Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more
Daily Brief: Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more. ... them. UK MARKET ACCESS. NICE says no to Chiesi’s rare disease drug.
-
Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more
Gottlieb sets out cell and gene pathway, NICE says no to Chiesi ultra-rare treatment and more. ... them. UK MARKET ACCESS. NICE says no to Chiesi’s rare disease drug.
-
Chiesi's ultra-rare genetic disorder therapy wins European backing
Chiesi's ultra-rare genetic disorder therapy wins European backing. Lamzede is set to become the first approved therapy for Alpha-Mannosidosis. ... It’s the second most advanced product from Chiesi’s rare disease unit after its LSCD therapy Holoclar
-
AZ’s COPD triple data sets up market clash with GSK
In Europe it was pipped to the post by Chiesi, which got a green light for its Trimbow (formoterol fumarate, glycopyrronium and beclomethasone) product, but this medicine must be administered
More from news
Approximately 13 fully matching, plus 30 partially matching documents found.
Latest Intelligence
-
The good, the bad and the ugly
GSK, AZ and Chiesi are each playing in this new market.
-
Deal Watch May 2016
911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.
-
Anticipating the future in healthcare
The technology was licensed from the Dutch bio company uniQure BV by Chiesi, a mid-sized, family-owned pharma company based in Parma, Italy. ... Paolo Chiesi, chairman of the board of directors, and Andrea Chiesi, CEO of Chiesi Farmaceutici, are part of
-
Deal Watch table for September 2013
Cornerstone Therapeutics/ Chiesi Farmaceutici. Acquisition (42 per cent). US speciality pharmaceutical company focused hospital and niche respiratory products. ... 2. Global rights excluding India, Pakistan and China. 3. Acquisition of the shares not
-
Pharma deals during October 2012
In keeping with Chiesi's marketing capabilities, the licence is for certain countries, including Europe, Turkey and CIS countries. ... 58. † Veloxis Pharmaceuticals / Chiesi Farmaceutici. Licence. LCP-Tacro (tacrolimus) immunosuppressant for kidney
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Akinion’s Dr Richard Jones joins Holostem Terapie Avanzate
Dr Paolo Chiesi, chairman of the board at Holostem, said: “ On behalf of the Holostem board, I am delighted to welcome Richard to the company. “
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
M&F Health
Chiesi. Clic Sargent. Clinimed. Danone. Dig . Early Years Nutirion Partnership. Janssen.
-
Random42 Scientific Communication
Boston Biomedical. Boston Scientific . Bristol-Myers Squibb. BTG. Celgene. Ceva. Chiesi. Cidara Therapeutics.
-
Random42 Scientific Communication
Boston Biomedical. Boston Scientific . Bristol-Myers Squibb. BTG. Celgene. Ceva. Chiesi. Cidara Therapeutics.
-
Swordfish Advertising
Archimedes Pharma. Corporate. Chiesi. Fostair. Corporate. Clenil. Atimos. Danone. Infant feeding.
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Systematic Review Analyst - Oxford
-
Negotiable
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Associate Director
-
£75, 000-90, 000
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Medical Writers
-
Competitive Salary and Benefits
-
Senior Medical Writer
-
Competitive Salary
-
Account Director
-
Excellent benefits
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Account Manager / Senior Account Manager
-
35, 000-40, 000
Subscribe to our email news alerts
- Animal Health Diagnostics Market Forecast Showing 9.53% CAGR to 2022
- Iron Drugs Market Set to Register 9.27% CAGR to 2022
- Medical Device Manufacturing Outsourcing Market to Soar at 11.92% CAGR to 2022
- Plaque Modification Devices Market Forecast Showing 8.19% CAGR to 2022
- Radiotherapy Market | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2023
- Migraine Therapeutics Market Forecast Showing 5.38% CAGR to 2022
PMHub
Anatomy Health
We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
